Smith & Nephew (SNN) Short term Debt (2013 - 2023)
Smith & Nephew (SNN) posted quarterly Short term Debt of -$303.0 million for Q4 2023, down 284.76% on a QoQ basis from $164.0 million in Q4 2018.
Smith & Nephew (SNN) Short term Debt (2013 - 2023) Analysis & Trends
Smith & Nephew (SNN) has reported Short term Debt for 7 consecutive years, with -$303.0 million the latest figure, recorded in Q4 2023.
- Quarterly Short term Debt changed N/A year-over-year to -$303.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$303.0 million (changed N/A YoY) and the FY2023 annual result came in at -$303.0 million, changed N/A from the prior year.
- Short term Debt eased to -$303.0 million in Q4 2023 per SNN's latest filing, from $164.0 million in the prior quarter.
- Over the last five years, Short term Debt for SNN reached as high as -$303.0 million in Q4 2023 and fell as low as -$303.0 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -303.00 Mn |
| Dec 31, 2018 | 164.00 Mn |
| Jun 30, 2018 | -369.00 Mn |
| Dec 31, 2017 | 27.00 Mn |
| Dec 31, 2016 | 86.00 Mn |
| Dec 31, 2015 | 46.00 Mn |
| Jun 30, 2015 | 413.00 Mn |
| Dec 31, 2014 | 540.00 Mn |
| Mar 31, 2014 | 27.00 Mn |
| Dec 31, 2013 | 366.00 Mn |